The Penicillins and Streptomycins dosage market in China has displayed fluctuating trends over the past decade. From a market size value of 773.41 million USD in 2013, there was a slight decrease, stabilizing around 746.84 million USD in 2022 and a minor increase to 751.92 million USD in 2023. Notable year-on-year variations were observed, including a considerable 10.79% increase in 2021 followed by an 8.46% drop in 2022. The CAGR over the last five years stands at 0.72%, indicating a generally stagnant market with occasional upswings.
Future trends to watch for:
- Technological advancements and innovations in drug formulation.- Changing healthcare policies and antibiotic stewardship programs.- Increasing cases of antibiotic resistance influencing market demand.- Economic factors and healthcare expenditure in China impacting market dynamics.
